Cyclovirobuxine D Induces Autophagy-Associated Cell Death via the Akt/mTOR Pathway in MCF-7 Human Breast Cancer Cells

DOI Web Site Web Site PubMed 被引用文献1件 参考文献38件
  • Lu Jing
    Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-Sen University, China
  • Sun Duanping
    Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-Sen University, China
  • Gao Si
    Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-Sen University, China
  • Gao Ying
    Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-Sen University, China
  • Ye Jiantao
    Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-Sen University, China
  • Liu Peiqing
    Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-Sen University, China

この論文をさがす

抄録

Autophagy is a highly regulated and multi-step biological process that serves to remove damaged cytoplasmic components and organelles. It has been suggested that the activation of autophagy may be a promising therapeutic strategy for cancer treatment by triggering cell death. In this study, we reported that cyclovirobuxine D (CVB-D), an alkaloid component in a traditional Chinese herb, could induce autophagy in the MCF-7 human breast cancer cell line. CVB-D inhibited the viability of MCF-7 cells in a concentration- and time-dependent manner. Activation of autophagy was characterized by transmission electron microscopy, monodansylcadaverine staining, and expression of autophagy marker microtubule-associated protein 1 light chain 3 (LC3). After CVB-D treatment, a clear accumulation of autophagosomes was observed accompanied with elevated LC3 fluorescent puncta. Western blot analysis revealed that CVB-D significantly promoted the conversion from LC3-I to LC3-II and the expression of autophagy-related protein 5 (ATG5), which are both essential for autophagosome formation. On the other hand, CVB-D–induced autophagy and decrease in cell viability could be blocked by 3-methyladenine, a well-established autophagy inhibitor. Moreover, CVB-D attenuated the phosphorylation of Akt and mTOR, two pivotal suppressors in autophagy pathways. These findings shed new light on the pharmacological actions and mechanism of CVB-D and may support the potential utility of autophagy inducers in cancer treatment.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (38)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ